Atlas Trials

A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

Clinical trial NCT04757376 · COMPLETED

Trial details

NCT number
NCT04757376
Sponsor
Celltrion
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Postmenopausal Women With Osteoporosis
Start date
2021-06-17
Primary completion
2023-05-18
Enrollment
479

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.